ClinicalThought

Share

Program Content

Activities

  • <I>EGFR</i>ex20ins+ NSCLC: Testing
    Testing for EGFR Exon 20 Insertion Mutations, a New Targetable Biomarker in Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2021

    Expires: August 04, 2022

  • <i>EGFR</i> ex20ins+ NSCLC: Therapy
    My Thoughts on Recently Approved Therapies for EGFR Exon 20 Insertion Mutation–Positive Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 06, 2021

    Expires: October 05, 2022

Provided by

ProCE Banner

Supporters

Janssen Pharmaceutica NV